SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AngioDynamics - ANGO
An SI Board Since December 2004
Posts SubjectMarks Bans Symbol
45 7 0 ANGO
Emcee:  radman33 Type:  Unmoderated
Anyone following this company? Their finanacials seem in order, and endovascular laser treatment of varicose veins is rapidly becoming the standard of care. This will be a huge boost for ANGO.

AngioDynamics, Inc. (www.angiodynamics.com) designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease. It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA dilation catheters, thrombolytic products, image-guided vascular access products, endovascular laser venous system products, as well as drainage products.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
45AngioDynamics Seeks Biolitec Patents To Satisfy $75M Award Share us on: By SeaPaul Lee-6/20/2018
44AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation SPaul Lee-6/7/2017
43Justices Reject Biolitec's $70M Contempt Appeal By Dani Kass Law360,Paul Lee-11/30/2015
42 CERTIORARI DENIED 15-69 BIOLITEC AG, ET AL. V. ANGIODYNAMICS, INCPaul Lee-11/30/2015
41High Court Urged To Review $70M Biolitec Contempt Ruling By Kevin Penton Paul Lee-11/5/2015
40Justices Urged To Not Review Biolitec $70M Contempt Ruling By Kevin Penton Paul Lee-10/26/2015
39Biolitec Exec Still Ducking Depositions, Sanctions Bid Says Share us on: By MiPaul Lee-4/9/2015
38NanoKnife System Receives OPS Procedure Classification Codes in Germany Paul Lee-10/28/2014
37 Five Oral Presentations on Clinical Experience With NanoKnife® System FPaul Lee-3/29/2012
36AngioDynamics Reports Oncology/Surgery Division Developments U.S. distribution cPaul Lee-5/24/2011
35To the point: New ‘nanoknife’ reaches places surgeons unable to go before PublisPaul Lee-3/29/2011
34Just discovered there was a board for this stock. Just recently liked what I sawrichardred-8/22/2010
33IN THE PIPELINE: AngioDynamics Could Bring Safer Cancer Treatment By JenniferPaul Lee-9/2/2009
32First Lung Lesion and First Lymph Node Metastasis Treated With AngioDynamics IREPaul Lee-12/18/2008
31First Percutaneous Liver and Kidney Lesions Treated With AngioDynamics’ IRE TechPaul Lee-11/24/2008
30Radiofrequency Ablation Yields High Proportions of Sustained Complete Responses Paul Lee-7/14/2008
29First Human Use Demonstrates Effectiveness of Irreversible Electroporation TreatPaul Lee-4/24/2008
28I aggreePaul Lee-3/10/2008
27Paul, What a massacre on Friday. I picked up some shares at 10.50 area. I rJim P.-3/10/2008
26AngioDynamics Highlights Results From Preliminary Study of Centros(TM) Central VPaul Lee-1/23/2008
25Thanks for reply, I had figured fair value for ANGO at about 22 before money wJim P.-5/5/2007
24Don't follow it that close, but I do think it is very underpricedPaul Lee-5/5/2007
23Paul, How close do you keep tabs on ANGO? This is one of the slowest boards Jim P.-5/5/2007
22AngioDynamics Expands PTA Balloon Dilatation Catheter Portfolio with IntroductioPaul Lee-5/1/2007
21SeekingAlpha The Growth Factor: AngioDynamics Won't Settle Down Tuesday FebrPaul Lee-2/20/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):